Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Int J Biol Macromol ; 188: 678-688, 2021 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-34343590

RESUMEN

As high-efficiency, safe, and low-drug resistant antibacterial agents, silver nanoparticles (AgNPs) have been widely applied in food and biomedicine. AgNPs was prepared using mango peel extract (MPE) as green and cheap reducing agent and stabilizer. In addition, a novel of preservative film material was developed with polylactic acid (PLA) as protective and substrate. AgNPs was characterized by XPS, XRD and TEM, and the size of AgNPs were in the range of 2.5-6.5 nm. The addition of AgNPs improved the mechanical properties of the film and its barrier ability to water vapor and oxygen. The film exhibited excellent antibacterial properties, and the inhibition rate against Escherichia coli and Staphylococcus aureus were above 95%. Furthermore, in terms of safety, the silver migration and cytotoxicity of the film met the relevant standards, and the shelf life of strawberries was significantly extended.


Asunto(s)
Embalaje de Alimentos , Mangifera/química , Nanopartículas del Metal/química , Extractos Vegetales/química , Poliésteres/química , Plata/química , Animales , Compuestos de Bifenilo/química , Línea Celular , Supervivencia Celular/efectos de los fármacos , Óxidos N-Cíclicos/química , Escherichia coli/efectos de los fármacos , Fragaria , Humanos , Imidazoles/química , Nanopartículas del Metal/ultraestructura , Pruebas de Sensibilidad Microbiana , Tamaño de la Partícula , Espectroscopía de Fotoelectrones , Picratos/química , Plata/farmacología , Espectroscopía Infrarroja por Transformada de Fourier , Staphylococcus aureus/efectos de los fármacos , Termogravimetría , Agua/química , Difracción de Rayos X
2.
Artículo en Inglés | MEDLINE | ID: mdl-31731641

RESUMEN

This study aimed to examine the associations between the duration of folic acid (FA) supplementation, gestational diabetes mellitus (GDM), and adverse birth outcomes. A total of 950 mother-offspring pairs participated in the cohort study during 2015 in Changsha, China. The data were collected through home visits and perfected by maternal and child healthcare handbooks. Generalized linear models and stratified analyses were used for statistical analyses. The incidence of GDM in our cohort was 10.2%. FA supplementation for ≥3 months before pregnancy was associated with an increased risk of GDM (adjusted relative risk (aRR): 1.72; 95% CI: 1.17-2.53) and decreased risk of small-for-gestational-age (SGA) birth (aRR: 0.40; 95% CI: 0.18-0.88). In the group of FA supplementation for ≥3 months during pregnancy, GDM was associated with an increased risk of cesarean delivery (aRR: 1.36; 95% CI: 1.06-1.75) and macrosomia (aRR: 2.11; 95% CI: 1.06, 4.20), but the aRRs were lower than the RRMH 1.53 (95% CI: 1.01-2.34) and 2.43 (95% CI: 1.27-4.66). Our study suggested that the longer duration of FA supplementation before pregnancy might increase the risk of GDM, but decrease the risk of SGA birth. Longer duration of FA supplementation during pregnancy had beneficial effects on birth outcomes in women with GDM. Further studies should consider a larger sample size to confirm these findings.


Asunto(s)
Diabetes Gestacional/epidemiología , Suplementos Dietéticos , Ácido Fólico/administración & dosificación , Resultado del Embarazo/epidemiología , Adulto , Cesárea/estadística & datos numéricos , China/epidemiología , Estudios de Cohortes , Esquema de Medicación , Femenino , Macrosomía Fetal/epidemiología , Humanos , Recién Nacido , Recién Nacido Pequeño para la Edad Gestacional , Embarazo , Complicaciones del Embarazo/epidemiología , Aumento de Peso
3.
Artículo en Inglés | MEDLINE | ID: mdl-31374808

RESUMEN

At present, there is insufficient evidence on whether prenatal multi-micronutrient (MM) supplementation can be an antenatal nutritional intervention or not. This study aimed to explore the sustained effect of prenatal MM supplementation on early childhood health. A total of 939 mother-offspring pairs were followed up in the study between 2015 to 2018 in Changsha, China. Information was mainly collected through household surveys at the ages of 1, 3, 6, 8, 12, 18, 24, and 36 months. General linear models and generalized estimating equation models were used to estimate the effects of maternal prenatal MM compared with IFA supplementation on infant growth and development. Offspring of women who used prenatal MM compared with IFA supplements had lower weight-for-age z score (WAZ) (adjusted ß: -0.23, 95% CI: (-0.40, -0.06)) and weight-for-length z score (WLZ) (adjusted ß: -0.20, 95% CI: (-0.37, -0.02)) at 3 months old, but a reduced risk of obesity at birth (aRR: 0.30, 95% CI: 0.11-0.78) and being overweight at 3 months old (aRR: 0.52, 95% CI: 0.32-0.84). Moreover, offspring of women who used prenatal MM compared with IFA supplements had significantly higher scores for communication (adjusted ß: 0.41, 95% CI: 0.61-0.21), gross motor (adjusted ß: 0.68, 95% CI: 0.49-0.88), fine motor (adjusted ß: 1.64, 95% CI: 1.45-1.84), problem solving (adjusted ß: 0.29, 95% CI: 0.10-0.49), and personal-social (adjusted ß: 0.90, 95% CI: 0.70-1.10) skills at 36 months old. Prenatal MM supplementation could result in better infant growth in the first few months of life and improve development scores at the age of 3 years compared with IFA supplementation.


Asunto(s)
Suplementos Dietéticos , Crecimiento y Desarrollo/efectos de los fármacos , Micronutrientes/administración & dosificación , Vitaminas/administración & dosificación , Adulto , Preescolar , China , Femenino , Humanos , Lactante , Recién Nacido , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA